Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_provenance.
- NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_assertion description "[We demonstrate here that BGP-13, a new calcipotriene-based 1?,25-dihydroxyvitamin D3 analog that we synthesized in our laboratory, inhibits the growth of prostate cancer (LNCaP), breast cancer (MCF-7), and colon cancer (HT-29) cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_provenance.
- NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_assertion evidence source_evidence_literature NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_provenance.
- NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_assertion SIO_000772 22661288 NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_provenance.
- NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_assertion wasDerivedFrom befree-2016 NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_provenance.
- NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_assertion wasGeneratedBy ECO_0000203 NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_provenance.
- befree-2016 importedOn "2016-02-19" NP986790.RAEY6XCvnYHY5uB0hPbVXaO2Qz0hsa16L0cyoTUDgthno130_provenance.